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http:WHAT THIS PAPER ADDS
This large retrospective study looks at the risk of early recurrent ipsilateral stroke in patients with symptomatic
carotid artery stenosis. A low risk that seems to coincide with improved medical treatment and is in line with
other recent studies was found. This knowledge is important to understand how to best treat patients with
symptomatic carotid stenosis and balance the risk of very early carotid endarterectomy.Objectives: The risk of recurrent stroke in patients with symptomatic carotid artery stenosis is highest in the ﬁrst
weeks after a transient ischemic attack (TIA) or minor stroke and can be reduced with carotid endarterectomy
(CEA). The optimal timing of CEA remains a controversial issue since very urgent CEA is associated with an
increased procedural risk. The aim of this study was to determine the risk of very early recurrent stroke in a
population with symptomatic high grade carotid stenosis.
Methods: Data were analyzed on all patients with ocular TIA, TIA, or minor stroke with >70% carotid stenosis
as assessed by carotid ultrasound at Sahlgrenska University Hospital during the periods 2004e2006 and 2010e
2012. The two time periods were chosen to minimize selection bias and to analyze changes over time. The risk of
recurrent stroke within 30 days of the referring event was assessed.
Results: 397 patients with symptomatic carotid stenosis were identiﬁed. The risk of recurrent stroke in the total
cohort was 2.0% (CI 95% 0.6e3.4) by day 2, 4.0% (CI 95% 2.0e5.9) by day 7, and 7.5% (CI 95% 4.4e10.6) by day
30. There was no signiﬁcant difference between the two time periods. Patients with minor stroke had a
signiﬁcantly higher risk of recurrent stroke than patients with TIA or ocular TIA as the referring event.
Conclusions: The data suggest that the early risk of recurrent stroke in symptomatic signiﬁcant carotid stenosis is
not as high as some earlier studies have shown. The risk is similar to several studies in which a modern medical
treatment regime could be assumed.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Stroke is the third most common cause of death in indus-
trialized countries. Transient ischemic attack (TIA) or mild
disabling stroke is sometimes a warning sign preceding a
severe disabling stroke. Extracranial internal carotid artery
stenosis is associated with around 10% of all ischemic
strokes.1 Patients with a high grade symptomatic carotid
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//dx.doi.org/10.1016/j.ejvs.2014.11.004with other causes of their neurological vascular events.2,3 A
number of studies show that the risk of recurrent stroke is
highest in the ﬁrst weeks after TIA or minor stroke but very
few studies have been designed to investigate the risk in
patients with carotid stenosis in the very early phase (within
2 days of the referring event).2,4e10
The North American Symptomatic Carotid Endarterec-
tomy Trial (NASCET) and the European Carotid Surgery Trial
(ECST) showed that carotid endarterectomy (CEA) for a
symptomatic carotid stenosis can reduce the overall risk of
recurrent stroke when performed within 6 months of a
neurological ischemic event.11,12 A pooled analysis from
these trials concluded that most of the beneﬁt is seen if
surgery is performed within 2 weeks of the referring
event.13 Current guidelines therefore promote early CEA of
symptomatic carotid artery stenosis to reduce the risk of
recurrent stroke.14e16 However, the recent analysis of data
from the Swedish Vascular Registry (Swedvasc) showed that
138 S. Strömberg et al.the post-operative complication rate is increased when CEA
is performed within 2 days of the referring event, 11.5% on
days 0e2 compared with 3.6% on days 3e7, suggesting that
adoption of a strategy with very early CEA may not be
beneﬁcial.17
To optimize the timing of CEA, there is an urgent need for
more studies describing the course of symptomatic carotid
stenosis with urgent medical treatment alone in the very
early phase after the referring event. The aim of the current
study was to determine the risk of early recurrent stroke in
a large group of patients who had high grade stenosis and
were clinically eligible for carotid surgery. Patients were
included in the study at the time of their ultrasound ex-
amination to minimize bias caused by early recurrent
strokes. The study cohort consisted of consecutive patients
in everyday clinical practice in a deﬁned geographical area
of western Sweden.
METHODS
Patients and duplex investigation
Data from all patients who received ultrasound examination
of the carotid arteries during the periods 2004e2006
(n ¼ 4632) and 2010e2012 (n ¼ 6456) at Sahlgrenska Uni-
versity Hospital were analyzed retrospectively (Fig. 1). The
timing of the duplex investigation in relation to the referring
neurological event was set by the clinical practice at that
time. The patients were identiﬁed through the WesternFigure 1. Flow diagram of patients included in the study.Region INitiative to Gather information on Atherosclerosis
(WINGA) registry, which holds information on the clinical
results of all carotid ultrasound examinations performed at
Sahlgrenska University Hospital from 1 January 2004. Sig-
niﬁcant carotid stenosis was deﬁned according to local
guidelines as 70% carotid obstruction due to atheroscle-
rosis on either or both sides according to the ECST criteria
using Doppler velocity criteria adapted for duplex ultra-
sound.18 A80% carotid stenosis according to ECST equates
to a 70% carotid stenosis when using NASCET criteria.
Similarly, a 60e79% stenosis according to ECST equates to a
50e69% carotid stenosis according to NASCET.
The medical records of each patient identiﬁed with sig-
niﬁcant carotid stenosis were searched manually to identify
the referring event (i.e., the neurological event that brought
the patient to hospital or general practitioner). Patients
who were asymptomatic or had an ipsilateral occlusion of
the carotid artery were excluded. Also excluded were pa-
tients with a major stroke as the referring event because
these patients are not considered suitable for acute CEA,
and it is difﬁcult to verify a recurrent event following a
recent severely disabling stroke. Also excluded were pa-
tients with stroke in evolution with continuous worsening of
symptoms, since the potential beneﬁt of CEA in these pa-
tients is unknown (Fig. 1).19,20 The referring event was
classiﬁed as ocular TIA, TIA, or minor stroke. Patients with
crescendo TIA were included in the TIA group. The charac-
teristics of the patients included in the study are thus a
cohort that was assessed for potential CEA.
Medical records were searched to determine if and when
CEA was performed and to identify all new cerebrovascular
strokes ipsilateral to the referring event (either before or
after ultrasound) for up to 30 days after the referring event.
Patients were censored at the time of recurrent event or
CEA. To ensure that no recurrent neurological event had
been missed, patients who did not undergo CEA or who
suffered a recurrent event during the 30 days after the
referring event were only included in the study if a medical
record existed conﬁrming that they were free of recurrent
cerebrovascular disease beyond the 30 day observation
period.
Sahlgrenska University Hospital is the sole supplier of
vascular diagnostics in the Gothenburg region, which has
approximately 650,000 inhabitants. Ultrasound is the rec-
ommended ﬁrst line investigative tool for carotid arteries in
stroke evaluation according to strict local guidelines. The
study thus included all patients in this region who were
referred for evaluation of carotid atherosclerotic disease, or
who were suffering from stroke or TIA. Importantly, inclu-
sion of patients at the time of ultrasound assured that this
was done before any decision on CEA was made. Thus, the
study cohort includes patients at risk of suffering a recur-
rent stroke while waiting for the decision on CEA.Recurrent stroke
Recurrent stroke (the endpoint) was deﬁned as a stroke
with neurological symptoms ipsilateral to the referring
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with minor stroke as the referring event were considered as
having a recurrent stroke if clinical worsening of symptoms
was clearly described in their medical records. In all patients
with initial minor stroke and recurrent stroke the National
Institutes of Health Stroke Score (NIHSS) was registered in
the medical record, and no patient had less than 3 points
worsening of the NIHSS. Recurrent TIAs were not included
in the analysis.Study groups
Recent guidelines for carotid surgery have recommended
shorter times between the referring event, vascular di-
agnostics, and CEA.16,20 In 2010, Sahlgrenska University
Hospital increased the availability of vascular ultrasound to
7 days a week, and many ultrasound examinations are now
performed within the ﬁrst days of hospitalization. Therefore,
patients were included from two different periods (2004e
2006 and 2010e2012) and it was predicted that the
average time between referring event, ultrasound, and CEA
would be longer for patients from the 2004e2006 period
than for patients from the 2010e2012 period. A longer
time between referring event and ultrasound would result
in increased time for follow up but has the disadvantage
that some patients with very early recurrence would be
excluded (i.e., if they have a severe disabling or fatal stroke
and were therefore not examined by ultrasound). In an
attempt to investigate risk of recurrent stroke in a group
where exclusion due to very early recurrence was mini-
mized, the total cohort was divided into two groups
depending on the interval between referring event and
ultrasound of the carotid arteries (0e1 days and 2 or more
days).Procedural risk
The procedural risk associated with CEA in a large Swedish
population has been reported previously.17 A fourfold
increased procedural risk was found when CEA was per-
formed on days 0e2 compared with days 3e7. Although
the current study is much smaller, procedural risk (deﬁned
as stroke or death within 30 days of CEA) was monitored. All
patients undergoing CEA had a neurological examination at
discharge and 30 days post-operatively. Post-operative
stroke was deﬁned as any stroke (independent of laterali-
zation) within 30 days described in the medical record. All
deaths were assessed.Ethics
The study was approved by the regional ethical review
board in Gothenburg.Statistical analysis
Descriptive statistics are presented as mean, standard de-
viation (SD, median and range for continuous variables and
with number and percentages for dichotomous variables.For comparison between two groups the chi-square test
was used. Time to recurrent stroke was described with
KaplaneMeier curves and analyzed between two groups
with the log-rank test. Time to recurrent stroke was
censored at CEA. All signiﬁcance tests were two sided and
conducted at the 5% signiﬁcance level. All analyses were
performed using SPSS (19.0) or SAS System Version 9.RESULTS
Patient characteristics
In total, 852 patients with ultrasound veriﬁed signiﬁcant
carotid stenosis were found in the registry. The medical
records were studied, and 392 patients were excluded due
to asymptomatic carotid stenosis. Five patients had
continuously worsening of symptoms during the ﬁrst hours
after referral and were therefore not included in the main
analyses. Also, 23 patients with major stroke as referring
event and 33 patients with ipsilateral occlusion were not
included.
The remaining 397 patients with ultrasound veriﬁed sig-
niﬁcant symptomatic carotid stenosis were included in the
study (2004e2006, n ¼ 194; 2010e2012, n ¼ 203; Fig. 1).
As predicted, the development of the vascular diagnostic
service between the two time periods signiﬁcantly reduced
the time between referring event and ultrasound (2004e
2006, median time 6 days [IQR 3e20]; 2010e2012, median
time 3 days [IQR 1e7]; p < .005) and between referring
event and CEA [2004e2006, CEA n ¼ 145, median time 36
days (IQR 17e83); 2010e2012, CEA n ¼ 167, median time 7
days (IQR 4e13); p < .005]. However, time between
referring event and hospitalization was not signiﬁcantly
different in the two time periods with 72.2% and 52.7% of
the patients hospitalized on the day of their referring event
in the early and late groups, respectively (p ¼ .422).
Table 1 shows the demographics and clinical variables of
the total cohort with the patients divided into two groups
depending on time between referring event and carotid
ultrasound (0e1 days and 2 or more days) and divided into
the two cohorts 2004e2006 and 2010e2012. The group
that was examined by ultrasound 0e1 day after the index
event was dominated by patients from the 2010e2012
period (77.3%). The two groups also differ in the distribu-
tion of referring event, with signiﬁcantly more TIAs in the
group examined by ultrasound 0e1 day after the referring
event. The only signiﬁcant differences between the early
and late cohort were in distribution of gender and contra-
lateral stenosis.Risk of early recurrent events
The risk of recurrent stroke in the full cohort of 397 patients
over the 30 day period after the referring event is shown in
Fig. 2A. The risk of recurrent stroke was 2.0% (CI 95% 0.6e
3.4) by day 2, 4.0% (CI 95% 2.0e5.9) by day 7, and 7.5% (CI
95% 4.4e10.6) by day 30. If the ﬁve patients with stroke in
evolution (continuous worsening of symptoms) were
included in the analyses the risk would be 3.2% by day 2.
Table 1. Demographics, co-morbidity and index events in the total cohort and subdivided according to time between index event and
ultrasound.
Total Ultrasound 0e1
days after index
event
Ultrasound 2
days after index
event
p 2004e2006 2010e2012 p
No. (%) 397 75 (18.9) 322 (81.1) 194 (48.9) 203 (51.1)
Mean age, y (SD) 72.0 (9.6) 73.4 (10.0) 71.7 (9.4) .160 70.4 (9.6) 73.5 (9.4) .001
Males, no. (%) 253 (63.7) 51 (68.0) 202 (62.7) .393 133 (68.6) 120 (59.1) .050
Hypertension, no (%) 254 (64.0) 47 (62.7) 207 (64.3) .793 131 (67.5) 123 (60.6) .150
Diabetes mellitus, no (%) 83 (20.9) 15 (20.0) 68 (21.1) .830 36 (18.6) 47 (23.2) .260
Heart disease, no. (%) 106 (26.7) 23 (30.7) 83 (25.8) .389 53 (27.3) 53 (26.1) .785
Current smoker, no. (%) 96 (24.2) 16 (21.3) 80 (26.4) .600 52 (28.4) 44 (22.9) .103
Ipsilateral stenosis 80%, no (%) 281 (70.8) 52 (69.3) 229 (71.1) .760 138 (71.1) 143 (70.4) .880
Contralateral
stenosis 70%, no (%)
69 (17.4) 11 (14.7) 58 (18.0) .491 41 (21.1) 28 (13.8) .054
Amaurosis fugax as
index event, no. (%)
70 (17.6) 11 (14.7) 59 (18.3) .454 31 (16.0) 39 (19.2) .398
TIA as index event, no. (%) 145 (36.5) 40 (53.3) 105 (32.6) .001 67 (34.5) 78 (38.4) .421
Minor stroke as index
event, no. (%)
182 (45.8) 24 (32.0) 158 (49.1) .008 96 (49.5) 86 (42.4) .155
Patients from time period
2010e2012, no. (%)
203 (51.1) 58 (77.3) 145 (45.0) <.005
TIA, transient ischemic attack. p-values comparing the two subgroups.
140 S. Strömberg et al.The risk of ipsilateral recurrent stroke in the two sub-
groups divided according to time to ultrasound of the ca-
rotid arteries (0e1 days and 2 or more days between
referring event and carotid imaging) is shown in Fig. 2B.
Notably, in the group where ultrasound was performed 0e
1 day after the referring event (n ¼ 75), there were no
ipsilateral recurrent strokes in the 0e1 day group at day 2
and only four patients (5.3%) had been censored at this
time due to early CEA (0e2 days). After 1 week, 41% of the
patients in this group had been censored and the cumu-
lative risk of ipsilateral recurrent stroke was 4.1% (95% CI
0e9.6). The 30 day risk of having a recurrent stroke in this
group was 9.0% (CI 95% 0e18.9). No signiﬁcant differences
regarding ipsilateral recurrent stroke between the groups
were seen. Of 283 patients with a high grade stenosis
80% (ECST), 20 patients (7.1%) suffered a recurrent stroke
within 30 days compared with three patients (2.6%) of 114
with a 70e79% stenosis (ECST) (p ¼ .079). Table 2 shows
the demographics and clinical variables comparing the 23
patients with recurrent stroke to 374 patients with no
recurrent stroke. Almost two thirds of the patients with
recurrent stroke are from the earlier cohort (non-
signiﬁcant).
Recurrent stroke in relation to referring event
No patient with ocular TIA had a recurrent stroke, and 17 of
the patients with recurrent stroke had minor stroke as
referring event (73.9%). The cumulative risk of recurrent
stroke for patients with TIA as referring event was by day 2
0.7% (95% CI 0e2.1), by day 7 2.3% (95% CI 0e5.2), and by
day 30 6.8% (95% CI 0e13.8). The same results for patients
with minor stroke as referring event were by day 2 3.8%
(95% CI 1.0e6.6), by day 7 6.7% (95% CI 2.5e10.9), and by
day 30 10.8% (95% CI 4.7e16.9). Patients with minor stroke
as the referring event have a signiﬁcantly higher risk ofrecurrent stroke than patients with TIA or ocular TIA
(p ¼ .021).Procedural risk
CEA was performed in 312 (78.6%) patients. The overall 30
day post-operative risk of any stroke and/or death was 5.8%
(n ¼ 18). In the group of patients having CEA 0e2 days after
the index event, three of 15 patients (20%) suffered post-
operative stroke compared with 15 of 297 patients (5.0%)
in the group having CEA after day 2. The risk of procedural
related stroke or death showed a signiﬁcant difference
comparing very early (0e2 days) and delayed (>2 days) CEA
(p ¼ .016). There were no signiﬁcant differences between
referring event and procedural risk. Approximately one third
(27.8%) of the patients with post-operative stroke had mi-
nor stroke as the referring event, 44.4% had TIA and 27.8%
had ocular TIA.
DISCUSSION
The optimal timing of CEA within the early period after an
initial TIA or minor stroke remains a controversial issue.
From previous studies, it is known that the risk of recurrent
stroke is highest in the early phase after a cerebrovascular
event; however, the peri-operative risk associated with CEA
also appears to be higher in this ﬁrst vulnerable
phase.5,7,17,21 These observations result in a difﬁcult trade
off between risk and beneﬁt in the timing of CEA. This study
showed that the risk of very early ipsilateral recurrent
stroke from the time of referring event in a large unselected
group of patients (n ¼ 397) with symptomatic ultrasound
veriﬁed high grade carotid stenosis was 2.0% by day 2, 4.0%
by day 7, and 7.5% by day 30. Furthermore, no recurrent
events were observed by day 2 in a subgroup of patients
(n ¼ 75) recruited to the study 0e1 day after the referring
Figure 2. The risk of ipsilateral recurrent stroke in patients with amaurosis fugax, transient ischemic attack or minor stroke and ultrasound
veriﬁed carotid stenosis (70%). Censored on the day of carotid endarterectomy. (A) Total population (n ¼ 397) with CI 95% marked in
grey. (B) Total population divided into 2 groups depending on time between index event and ultrasound of the carotid arteries (0e1 days
[n ¼ 75] and 2 or more days [n ¼ 322]). Patients remaining in the study at 2, 7, and 30 days are seen at the bottom of the graph.
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with extremely low risk of selection bias, and the total
cohort were seen. A potential limitation in this study is that
an acute ultrasound in some cases probably is associated
with recurrent TIA and thus increased risk of recurrent
stroke. However, only four patients were censored on day 2
due to acute CEA. At day 7, only 28 patients were left at risk
in the group with early ultrasound examination. This could
be one reason why the study shows a lower prevalence of
recurrent stroke than other studies.Two time periods with different strengths and weak-
nesses were chosen. As expected, the follow up time (be-
tween referring event and CEA) was longer in patients from
the earlier time period (2004e2006) than the later time
period (2010e2012), explained by increased adherence to
guidelines promoting early CEA in recent years. In addition,
time from referring event to ultrasound decreased signiﬁ-
cantly between the two periods. This is probably explained
by the increased availability of vascular ultrasound at the
study hospital (availability is 7 days a week from 2010).
Table 2. Demographics, co-morbidity and index events in the total cohort and subdivided to patients with recurrent stroke and with no
recurrent stroke.
Total Recurrent stroke No recurrent stroke p
No. (%) 397 23 (5.8) 374 (94.2)
Mean age, yrs (SD) 72.0 (9.6) 72.1 (9.9) 72.0 (9.6) .964
Males, no. (%) 253 (63.7) 15 (65.2) 238 (63.6) .878
Hypertension, no. (%) 254 (64.0) 18 (78.3) 236 (63.1) .142
Diabetes mellitus, no. (%) 83 (20.9) 6 (26.1) 77 (20.6) .529
Heart disease, no. (%) 106 (26.7) 7 (30.4) 99 (26.5) .677
Current smoker, no. (%) 96 (24.2) 5 (22.7) 91 (25.8) .509
Ipsilateral stenosis 80%, no. (%) 281 (70.8) 20 (87.0) 261 (69.8) .079
Contralateral stenosis 70%, no (%) 69 (17.4) 3 (13.0) 66 (17.6) .572
Amaurosis fugax as index event, no. (%) 70 (17.6) 0 (0.0) 70 (18.7) .022
TIA as index event, no. (%) 145 (36.5) 6 (26.1) 139 (37.2) .284
Minor stroke as index event, no. (%) 182 (45.8) 17 (73.9) 165 (44.1) .005
Neurological symptoms within 6 months before
index event, no. (%)
156 (39.2) 7 (30.4) 149 (39.8) .449
Patients from time period 2010e2012, no. (%) 203 (51.1) 9 (39.1) 194 (51.9) .235
Patients from time period 2004e2006, no. (%) 194 (48.9) 14 (60.9) 180 (48.1) .235
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period had the disadvantage of short follow up (with many
cases censored early because of early CEA), it overcame, to
some extent, the selection bias encountered in analysis of
patients from the earlier time period because of delay be-
tween referring event and ultrasound. There were no sig-
niﬁcant differences in recurrent events between the two
time periods (p ¼ .235), even though almost two thirds of
the patients with recurrent stroke were from the earlier
cohort.
A national campaign was started in Sweden 2011 to
encourage patients with a cerebrovascular event to seek
medical attention immediately following a TIA or stroke.
This did result in more ultrasounds of symptomatic carotid
disease in the time period 2010e2012 but not in the inci-
dence of carotid disease (Fig. 1). This could be explained by
a concomitant decreased incidence of stroke and even
symptomatic high grade carotid stenosis.22 It is also likely
that the incidence of recurrence has decreased with time. If
the incidence of recurrence over time had been similar we
would probably have seen a higher frequency of recurrent
stroke in the later time period since the prompt ultrasound
minimizes the possibility of losing patients with very early
recurrence.
A number of earlier studies have investigated the risk of
recurrent stroke in patients with symptomatic carotid ste-
nosis. However, extrapolation of data from these studies is
sometimes difﬁcult due to potential selection bias and
different deﬁnitions of both index event and recurrent
event. A high risk of recurrent stroke in the early phase after
an index event has been reported by Fairhead et al.5 (13%
(95% CI 1e24) within 14 days of an index event but the
number of observations was very small in this study
(n ¼ 32). Ois et al.7 reported a high risk of early recurrent
stroke in a larger population (17.2% within 3 days of an
index event, n ¼ 163); however, in contrast to this study,
TIAs and stroke in evolution were registered as recurrent
events, which could partly explain the higher risk.Johansson et al.8 described the risk of recurrent stroke in a
large Swedish study (5.2% by day 2, n ¼ 230); however, the
majority of the patients are from remote hospitals and
there is a risk of selection bias in the referrals.8 In another
recent study with short time to follow up, Mono et al.23
reported a low risk of recurrent stroke (1.1% in 3 days,
n ¼ 94). However, more than 20% of the patients in Mono’s
study underwent CEA within 48 hours of the referring
event, resulting in a very short follow up. The conclusion of
these studies is that the majority of modern studies support
the ﬁndings with a risk of recurrent stroke within the ﬁrst
few days of the index event being around 1e5%. However,
there are still some studies, in particular earlier studies with
a much higher incidence of recurrence, that cannot be
ignored.5,24
There are also a number of studies regarding risk of
recurrence in patients awaiting CEA. Marnane et al.25
included 36 patients with ischemic stroke and symptom-
atic carotid stenosis and among those, two patients had a
recurrent stroke within 72 hours, (5.6%, 95% CI 1.4e20.4).
Salem et al.26 show the increased risk of recurrence in pa-
tients with large lipid core plaques, but only one of 158
patients with symptomatic carotid stenosis suffered a
recurrent stroke awaiting surgery. In this study, all patients
were treated with statins following admission. Ali et al.27
show a high incidence of recurrence within 48 hours. Two
of 89 patients had a disabling stroke within 48 hours
awaiting surgery. Almost 40% had CEA performed within 48
hours, with the consequence that the risk of recurrent
stroke might be much higher than this study shows due to
missing follow up.
Interestingly, Merwick et al.28 presented a recent study in
which the beneﬁt of statin treatment as stroke prevention
was investigated. In a large pooled analysis, patients with
TIA due to carotid artery stenosis had a signiﬁcantly lower 7
day stroke risk if treated with statins (3.8% vs. 13.2% for
non-treated patients). In the current study, complete data
on the use of statins in the whole cohort could not be
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medical treatment in 147 out of 197 patients, and 53%
were treated with statins when leaving hospital. In 2010e
2012, only data on patients receiving CEA (n ¼ 170) were
available; however, 97% were treated with statins after
their neurological event in this group. There is obviously a
distinct change in medical treatment over time in this pa-
tient group. There were no explicit changes in guidelines
regarding medical treatment at the hospital in the study
period; however, an increased awareness of the need for
early and aggressive medical treatment to prevent recur-
rence has been seen. Aggressive use of statins in patients
with previous cardiovascular disease has been advocated in
clinical practice in the past decade and it is thus likely that
most of the patients with a history of any cardiovascular
disease are treated with statins. Furthermore, statin treat-
ment is promptly initiated when patients are diagnosed
with TIA or stroke, which has been shown to reduce the risk
of recurrent stroke.29,30 Also, regarding antiplatelet therapy,
modern treatment strategies seem to have been imple-
mented. In 2004e2006 only 4% had clopidogrel when
leaving hospital while in 2010e2012 36% were on it.
CONCLUSION
The data suggest that the early risk of recurrent stroke in
symptomatic signiﬁcant carotid stenosis is not as high as
some earlier studies have shown, but similar to several
modern studies in which a modern medical treatment
regimen could be assumed. The risk of having a recurrent
event must be balanced against the risk of procedural
complications of CEA. Randomized, multicenter trials or
large prospective studies are required to determine the
optimal timing of CEA. However, on the basis of these re-
sults, immediate diagnostic evaluation and medical treat-
ment should be promoted. Surgical treatment should be
performed as soon as possible but presumably not within
the ﬁrst 2 days from the referring event because of
increased procedural risk.
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